Related Experiment Video
Updated: May 16, 2026

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Published on: February 1, 2018
A SiQD-based hydrogel fiber sensor for portable, on-site β-galactosidase detection in serum
Dan Li1, Yutao Shen1, Zikai Xu1
1School of Intelligent Sensing and Optoelectronic Engineering, Hebei Key Laboratory of Micro-Nano Precision Optical Sensing and Measurement Technology, Northeastern University at Qinhuangdao, Qinhuangdao 066004, China. lidan1@neuq.edu.cn.
None:
β-Galactosidase (β-Gal), a key senescence biomarker, is crucial for early diagnosis and treatment. In this work, a portable fluorescent fiber optic sensor, based on hydrogel technology, has been designed to monitor β-Gal activity. A tapered optical fiber probe was functionalized with green-emitting silicon quantum dots (SiQDs) via in situ hydrogel polymerization. The sensor ingeniously exploits a β-Gal-initiated cascade reaction: the hydrolysis of the substrate by β-Gal releases a reductant, which promotes the conversion of the Cu(II) chelate into its chromogenic Cu(I) counterpart; the resultant Cu(I) species, in turn, quench the fluorescence of SiQDs via an inner-filter effect. This sensor showed a linear response for β-Gal between 2.0 and 15.0 U L-1, achieving an analytical sensitivity threshold of 1.60 U L-1. It exhibited a combination of high sensitivity, excellent selectivity, strong anti-interference capability, facile fabrication and portability. The sensor accurately quantified β-Gal in real serum and urine samples, with reliability confirmed through standard-addition recovery tests. This represents a mobile, highly effective approach for online, ultratrace β-Gal activity detection in biological specimens and opens new avenues for portable biosensor development.
More Related Videos
13:42Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
Published on: September 19, 2017
07:39SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019